1. Home
  2. AAPG vs VSEC Comparison

AAPG vs VSEC Comparison

Compare AAPG & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • VSEC
  • Stock Information
  • Founded
  • AAPG 2009
  • VSEC 1959
  • Country
  • AAPG China
  • VSEC United States
  • Employees
  • AAPG N/A
  • VSEC N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • VSEC Military/Government/Technical
  • Sector
  • AAPG Health Care
  • VSEC Consumer Discretionary
  • Exchange
  • AAPG Nasdaq
  • VSEC Nasdaq
  • Market Cap
  • AAPG 2.2B
  • VSEC 2.1B
  • IPO Year
  • AAPG 2025
  • VSEC N/A
  • Fundamental
  • Price
  • AAPG $24.40
  • VSEC $130.09
  • Analyst Decision
  • AAPG Buy
  • VSEC Strong Buy
  • Analyst Count
  • AAPG 1
  • VSEC 6
  • Target Price
  • AAPG N/A
  • VSEC $125.17
  • AVG Volume (30 Days)
  • AAPG 14.1K
  • VSEC 282.9K
  • Earning Date
  • AAPG 06-10-2025
  • VSEC 05-06-2025
  • Dividend Yield
  • AAPG N/A
  • VSEC 0.31%
  • EPS Growth
  • AAPG N/A
  • VSEC N/A
  • EPS
  • AAPG N/A
  • VSEC 0.67
  • Revenue
  • AAPG $134,352,180.00
  • VSEC $1,173,794,000.00
  • Revenue This Year
  • AAPG N/A
  • VSEC $2.95
  • Revenue Next Year
  • AAPG $389.09
  • VSEC $11.60
  • P/E Ratio
  • AAPG N/A
  • VSEC $55.67
  • Revenue Growth
  • AAPG 341.77
  • VSEC 40.70
  • 52 Week Low
  • AAPG $16.50
  • VSEC $73.36
  • 52 Week High
  • AAPG $26.55
  • VSEC $139.51
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • VSEC 58.05
  • Support Level
  • AAPG N/A
  • VSEC $127.01
  • Resistance Level
  • AAPG N/A
  • VSEC $131.01
  • Average True Range (ATR)
  • AAPG 0.00
  • VSEC 4.04
  • MACD
  • AAPG 0.00
  • VSEC -0.58
  • Stochastic Oscillator
  • AAPG 0.00
  • VSEC 37.24

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management and consulting services for land, sea and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. Majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business and general aviation operators.

Share on Social Networks: